In a new job - September 1, 2021
Oasmia appoints Head of Clinical Development & Head of Regulatory Affairs
Oasmia Pharmaceutical has announced the appointments of Kia Bengtsson as Head of Clinical Development and Johanna Röstin as Head of Regulatory Affairs with effect from October 1, 2021. The appointments strengthen Oasmia’s internal drug development expertise as the company progresses its portfolio of cancer therapies through the clinic and evaluates opportunities to further expand the […]
In a new job - September 1, 2021
Affibody appoints new CMO
Affibody has appointed Nikolai Brun as its Chief Medical Officer. Brun will join the Affibody leadership team and will be responsible for the clinical safety, development and operations functions as well as regulatory affairs. Nikolai Brun Nikolai Brun has held a variety of clinical development leadership positions within the pharmaceutical industry over the last 20 […]
In a new job - September 1, 2021
Atlas Antibodies appoints new CEO
Nille Klæbel joins Atlas Antibodies from her role as CEO Nordics at Philips, a position she has held since 2018. Nille joined Philips back in 2013. Previously she has held senior positions at GlaxoSmithKline, Sanofi and Novo Nordisk. “We are delighted to welcome Nille as the new CEO of Atlas Antibodies,” says Torben Jørgensen, chairman […]
In a new job - September 1, 2021
She is the new CEO of Biotage
Maja Nilsson has been appointed as new CFO and member of Biotage AB Group Management, based out of the Group Headquarters in Uppsala, Sweden. “I am very happy to welcome Maja as new CFO for Biotage. Maja will be a key contributor in scaling up Biotage’s business going forward and I am convinced she will […]
In a new job - August 23, 2021
Ilya Pharma appoints new CFO in preparation for IPO
Ilya Pharma has announced that Oskar Lund has been appointed Chief Financial Officer. Lund joins at a pivotal stage in the company’s development as it eyes a potential IPO following recent positive results from the first in human (FIH) trial of its lead candidate ILP100 for treating difficult and chronic wounds, the company states. “Oskar […]
In a new job - August 16, 2021
SynAct appoints Vice President Finance and Director of Operational R&D
The company has announced the appointments of Patrik Renblad as Vice President Finance and Lise Agersted as Director of Operational R&D. “We are happy to welcome both Patrik and Lise to the SynAct team,” says SynAct’s CEO Jeppe Øvlesen. “Both are important additions as SynAct pushes forward on its bold strategy to become the leading […]
